NASDAQ:NRXP
NRx Pharmaceuticals, Inc. Stock News
$2.82
+0.0100 (+0.356%)
At Close: May 08, 2024
NRx Pharmaceuticals to Present at the Sidoti Virtual Small Cap Conference
06:46am, Monday, 18'th Sep 2023
RADNOR, Pa. , Sept. 18, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Stephen W
NRx Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
06:47am, Thursday, 07'th Sep 2023
RADNOR, Pa. , Sept. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that Stephen W
NRX Pharmaceuticals, Inc. (NRXP) Q2 2023 Earnings Call Transcript
09:58pm, Monday, 14'th Aug 2023
NRX Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q2 2023 Earnings Conference Call August 14, 2023 4:30 PM ET Company Participants Matthew Duffy - Chief Business Officer Steve Willard - CEO & Director Jonathan
NRx Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 14, 2023
06:47am, Monday, 07'th Aug 2023
RADNOR, Pa. , Aug. 7, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a late-stage biopharmaceutical company, today announced that it will releas
NRx Pharmaceuticals to Host Corporate and Strategic Update Conference Call on Monday, June 5, 2023
02:20pm, Friday, 02'nd Jun 2023
RADNOR, Pa. , June 2, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced it will host a c
All You Need to Know About NRx Pharmaceuticals, Inc. (NRXP) Rating Upgrade to Buy
01:01pm, Wednesday, 31'st May 2023
NRx Pharmaceuticals, Inc. (NRXP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
NRx Pharmaceuticals, Inc. (NRXP) Q4 2022 Earnings Call Transcript
10:10pm, Thursday, 30'th Mar 2023
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q4 2022 Earnings Conference Call March 30, 2023 4:30 PM ET Company Participants Suzanne Messere - IR Stephen Willard - CEO Seth Van Voorhees - CFO Jonathan Jav
NRx Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023
06:47am, Friday, 17'th Mar 2023
RADNOR, Pa. , March 17, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage CNS biopharmaceutical company, a Delaware Corporation, t
RADNOR, Pa. , Jan. 5, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage biopharmaceutical company, today announced that it will be
NRx Pharmaceuticals, Inc. (NRXP) Q3 2022 Earnings Call Transcript
09:52am, Monday, 14'th Nov 2022
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q3 2022 Earnings Conference Call November 14, 2022 8:00 AM ET Company Participants Suzanne Messere - Investor Relations Stephen Willard - Chief Executive Offic
5 Penny Stocks To Buy According To Analysts, Targets Up To 353%
10:38am, Friday, 11'th Nov 2022
Analysts say these are penny stocks to buy. Do you agree?
NRx Pharmaceuticals to Report Third Quarter 2022 Results on November 14, 2022
06:47am, Thursday, 10'th Nov 2022
--Company to Host Conference Call November 14, 2022, at 8:00AM ET--- RADNOR, Pa. , Nov. 10, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a cli
NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. 24th Annual Global Investment Conference
06:40am, Thursday, 08'th Sep 2022
Company to Present Corporate Update During Investor Conference, Sept. 14, 2022, at 9:00am ET RADNOR, Pa.
NRx Pharmaceuticals, Inc. (NRXP) CEO Stephen Willard on Q2 2022 Results - Earnings Call Transcript
12:51pm, Monday, 15'th Aug 2022
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q2 2022 Earnings Conference Call August 15, 2022 8:30 AM ET Company Participants Tom Johnson - Investor Relations Stephen Willard - Chief Executive Officer Set
NRx Pharmaceuticals to Report Second Quarter 2022 Results on August 15, 2022
07:45am, Wednesday, 10'th Aug 2022
--Company to Host Conference Call August 15th, 2022, at 8:30AM ET--- RADNOR, Pa. , Aug. 10, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a cli